Expertise

Morten Holmström obtained his master degree in medicine at the University of Copenhagen in 2011 and his PhD degree at the University of Copehagen in 2017. Doctor Holmström has developed and discovered several vaccination epitopes of which several have undergone testing in the clinic. From 2021 – 2023 he is employed as a postdoc at the University of Copenhagen BRIDGE Translational Excellence Program acquiring skills important for translational research during the extensive course curriculum in the program.

Primære forskningsområder

Doctor Holmström’s research is focused on tumor immunology in especially hematological cancers. Namely he has characterized neo-antigens found in the chronic myeloproliferative neoplasms and his findings provided the foundation for two vaccine trials performed at CCIT-DK. These trials were the first therapeutic cancer vaccine trials in the chronic myeloproliferative neoplasms and doctor Holmström has been invited several times as a speaker at international meetings dissertating the findings in these trials. 

Aktuel forskning

Doctor Holmström’s recent research is now focused on identification of new vaccination epitopes in both solid and hematological cancers. Additionally, he is occupied with finding new ways to improve the efficacy of cancer immune therapy in chronic myeloproliferative neoplasms.

Mulige interessekonflikter

None